EUVIMEDEUVIMED entdecken
Crossref

Assessment of AAV/polyketal chimeric nanoparticles for ocular gene transduction using an animal model

Brenda Fernanda Moreira Castro iD, Margaret Lugin iD, Maria Carolina Andrade Guerra iD, Marina França Dias iD, Rebecca T Lee, Armando Silva-Cunha iD, Young Jik Kwon iD, Silvia Ligório Fialho iD

Drug Delivery and Translational Research · 2025

DOI: 10.1007/s13346-025-02001-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2025. Verfasst von Brenda Fernanda Moreira Castro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Dependovirus, Nanoparticles, RNA, Small Interfering, Transduction, Genetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gene therapy has made significant progress in ophthalmology in recent years, particularly through adeno-associated virus (AAV)-mediated delivery. Despite well-known advantages of AAV vectors, their restricted cargo capacity, immunogenicity, and the presence of neutralizing antibodies against commonly used serotypes limit their use and efficacy. To address these limitations, we developed viral/nonviral chimeric nanoparticles (ChNPs) consisting of AAV2 vectors encapsulated by a polyketal acid-degradable polymeric shell and further functionalized with hyaluronic acid (HA). Additionally, a scrambled siRNA was incorporated into the polymeric shell to enable a multimodal therapeutic approach. In vitro safety, transduction efficiency and siRNA internalization of ChNPSs was investigated in retinal cells followed by an in vivo safety assessment for intravitreal delivery in rats. Characterization of ChNPs confirmed successful functionalization with HA, which resulted in improved size and uniformity as well as enhanced transduction efficiency in retinal cells when compared to HA-free ChNPs. Moreover, HA coating improved biocompatibility by maintaining retinal cells' viability when incubated with ChNPs and allowed efficient siRNA internalization. A comprehensive in vivo assessment demonstrated that both HA-conjugated and HA-free ChNPs preserved retinal function, integrity, and morphology. Furthermore, the intraocular pressure and retinal thickness was not affected by ChNPs, confirming their safety for intravitreal delivery. Therefore, ChNPs coated with HA represent a promising alternative to overcome challenges with the most widely employed AAV vector in ocular gene delivery. Our findings support the potential for intravitreal administration of ChNPs and in multimodal gene expression/silencing strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusNanoparticlesRNA, Small InterferingTransduction, GeneticGenetic VectorsAnimalsHyaluronic AcidRetinaRatsGenetic TherapyHumansMaleRats, Sprague-DawleyIntravitreal InjectionsGene Transfer Techniques

Stichwörter der Autor:innen

AAVChimeric nanoparticlesGene therapyOcular gene deliveryPolyketal shell

Substanzen

RNA, Small InterferingHyaluronic Acid

Autor:innen und Institutionen

  • Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Department of Chemical and Biomolecular Engineering, University of California, Irvine, USA.
  • Pharmaceutical Research and Development, Ezequiel Dias Foundation, Belo Horizonte, Minas Gerais, Brazil.
  • Department of Biomedical Engineering, University of California, Irvine, USA.
  • Department of Pharmaceutical Sciences, University of California, Irvine, USA.
  • Department of Molecular Biology and Biochemistry, University of California, Irvine, USA.

ORCID-Profile: Brenda Fernanda Moreira Castro, Margaret Lugin, Maria Carolina Andrade Guerra, Marina França Dias, Armando Silva-Cunha, Young Jik Kwon, Silvia Ligório Fialho

Förderung

  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Castro, B. F. M., Lugin, M., Guerra, M. C. A., Dias, M. F., Lee, R. T., Silva-Cunha, A., Kwon, Y. J., & Fialho, S. L. (2025). Assessment of AAV/polyketal chimeric nanoparticles for ocular gene transduction using an animal model. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-025-02001-9

Vancouver

Castro BFM, Lugin M, Guerra MCA, Dias MF, Lee RT, Silva-Cunha A, et al. Assessment of AAV/polyketal chimeric nanoparticles for ocular gene transduction using an animal model. Drug Delivery and Translational Research. 2025. doi:10.1007/s13346-025-02001-9

BibTeX
@article{Castro2025,
  author = {Castro, Brenda Fernanda Moreira and Lugin, Margaret and Guerra, Maria Carolina Andrade and Dias, Marina França and Lee, Rebecca T and Silva-Cunha, Armando and Kwon, Young Jik and Fialho, Silvia Ligório},
  title = {Assessment of AAV/polyketal chimeric nanoparticles for ocular gene transduction using an animal model},
  journal = {Drug Delivery and Translational Research},
  year = {2025},
  doi = {10.1007/s13346-025-02001-9}
}
Kostenlos starten →